215 related articles for article (PubMed ID: 24853589)
1. In silico predicted mycobacterial epitope elicits in vitro T-cell responses.
Khan MK; Zaman S; Chakraborty S; Chakravorty R; Alam MM; Bhuiyan TR; Rahman MJ; Fernández C; Qadri F; Seraj ZI
Mol Immunol; 2014 Sep; 61(1):16-22. PubMed ID: 24853589
[TBL] [Abstract][Full Text] [Related]
2. In silico analysis of potential human T Cell antigens from Mycobacterium tuberculosis for the development of subunit vaccines against tuberculosis.
Devasundaram S; Deenadayalan A; Raja A
Immunol Invest; 2014; 43(2):137-59. PubMed ID: 24467664
[TBL] [Abstract][Full Text] [Related]
3. Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferon.
Radosevic K; Wieland CW; Rodriguez A; Weverling GJ; Mintardjo R; Gillissen G; Vogels R; Skeiky YA; Hone DM; Sadoff JC; van der Poll T; Havenga M; Goudsmit J
Infect Immun; 2007 Aug; 75(8):4105-15. PubMed ID: 17526747
[TBL] [Abstract][Full Text] [Related]
4. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
5. A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity.
Hoft DF; Blazevic A; Stanley J; Landry B; Sizemore D; Kpamegan E; Gearhart J; Scott A; Kik S; Pau MG; Goudsmit J; McClain JB; Sadoff J
Vaccine; 2012 Mar; 30(12):2098-108. PubMed ID: 22296955
[TBL] [Abstract][Full Text] [Related]
6. A novel DNA vaccine containing multiple TB-specific epitopes cast in a natural structure elicits enhanced Th1 immunity compared with BCG.
Gao H; Li K; Yu S; Xiong S
Microbiol Immunol; 2009 Oct; 53(10):541-9. PubMed ID: 19780967
[TBL] [Abstract][Full Text] [Related]
7. Epitope-driven TB vaccine development: a streamlined approach using immuno-informatics, ELISpot assays, and HLA transgenic mice.
McMurry JA; Kimball S; Lee JH; Rivera D; Martin W; Weiner DB; Kutzler M; Sherman DR; Kornfeld H; De Groot AS
Curr Mol Med; 2007 Jun; 7(4):351-68. PubMed ID: 17584075
[TBL] [Abstract][Full Text] [Related]
8. Sequence conservation analysis and in silico human leukocyte antigen-peptide binding predictions for the Mtb72F and M72 tuberculosis candidate vaccine antigens.
Mortier MC; Jongert E; Mettens P; Ruelle JL
BMC Immunol; 2015 Oct; 16():63. PubMed ID: 26493839
[TBL] [Abstract][Full Text] [Related]
9. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
10. Subcutaneous administration of modified vaccinia virus Ankara expressing an Ag85B-ESAT6 fusion protein, but not an adenovirus-based vaccine, protects mice against intravenous challenge with Mycobacterium tuberculosis.
You Q; Jiang C; Wu Y; Yu X; Chen Y; Zhang X; Wei W; Wang Y; Tang Z; Jiang D; Wu Y; Wang C; Meng X; Zhao X; Kong W
Scand J Immunol; 2012 Jan; 75(1):77-84. PubMed ID: 21916923
[TBL] [Abstract][Full Text] [Related]
11. Protective CD4 T cells targeting cryptic epitopes of Mycobacterium tuberculosis resist infection-driven terminal differentiation.
Woodworth JS; Aagaard CS; Hansen PR; Cassidy JP; Agger EM; Andersen P
J Immunol; 2014 Apr; 192(7):3247-58. PubMed ID: 24574499
[TBL] [Abstract][Full Text] [Related]
12. Developing an epitope-driven tuberculosis (TB) vaccine.
De Groot AS; McMurry J; Marcon L; Franco J; Rivera D; Kutzler M; Weiner D; Martin B
Vaccine; 2005 Mar; 23(17-18):2121-31. PubMed ID: 15755582
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of immune response to a DNA vaccine against Mycobacterium tuberculosis Ag85B by incorporation of an autophagy inducing system.
Meerak J; Wanichwecharungruang SP; Palaga T
Vaccine; 2013 Jan; 31(5):784-90. PubMed ID: 23228812
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.
Nayak K; Jing L; Russell RM; Davies DH; Hermanson G; Molina DM; Liang X; Sherman DR; Kwok WW; Yang J; Kenneth J; Ahamed SF; Chandele A; Murali-Krishna K; Koelle DM
Tuberculosis (Edinb); 2015 May; 95(3):275-87. PubMed ID: 25857935
[TBL] [Abstract][Full Text] [Related]
15. Mucosal delivery of antigen-coated nanoparticles to lungs confers protective immunity against tuberculosis infection in mice.
Stylianou E; Diogo GR; Pepponi I; van Dolleweerd C; Arias MA; Locht C; Rider CC; Sibley L; Cutting SM; Loxley A; Ma JK; Reljic R
Eur J Immunol; 2014 Feb; 44(2):440-9. PubMed ID: 24214530
[TBL] [Abstract][Full Text] [Related]
16. Identification of CD4+ T-cell epitope and investigation of HLA distribution for the immunogenic proteins of Burkholderia pseudomallei using in silico approaches - A key vaccine development strategy for melioidosis.
Swetha RG; Sandhya M; Ramaiah S; Anbarasu A
J Theor Biol; 2016 Jul; 400():11-8. PubMed ID: 27086038
[TBL] [Abstract][Full Text] [Related]
17. Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity.
Joosten SA; van Meijgaarden KE; van Weeren PC; Kazi F; Geluk A; Savage ND; Drijfhout JW; Flower DR; Hanekom WA; Klein MR; Ottenhoff TH
PLoS Pathog; 2010 Feb; 6(2):e1000782. PubMed ID: 20195504
[TBL] [Abstract][Full Text] [Related]
18. Difference in TB10.4 T-cell epitope recognition following immunization with recombinant TB10.4, BCG or infection with Mycobacterium tuberculosis.
Billeskov R; Grandal MV; Poulsen C; Christensen JP; Winther N; Vingsbo-Lundberg C; Hoang TT; van Deurs B; Song YH; Aagaard C; Andersen P; Dietrich J
Eur J Immunol; 2010 May; 40(5):1342-54. PubMed ID: 20186878
[TBL] [Abstract][Full Text] [Related]
19. Identification and HLA restriction of naturally derived Th1-cell epitopes from the secreted Mycobacterium tuberculosis antigen 85B recognized by antigen-specific human CD4(+) T-cell lines.
Mustafa AS; Shaban FA; Abal AT; Al-Attiyah R; Wiker HG; Lundin KE; Oftung F; Huygen K
Infect Immun; 2000 Jul; 68(7):3933-40. PubMed ID: 10858206
[TBL] [Abstract][Full Text] [Related]
20. Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.
Jeyanathan M; Damjanovic D; Yao Y; Bramson J; Smaill F; Xing Z
J Infect Dis; 2016 Dec; 214(12):1996-2005. PubMed ID: 27703038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
